DaVita (NYSE:DVA) Q3 results:
Revenues: $2,904.1M (+2.0%); dialysis & related lab services: $2,781,2M (+4.1%).
Net income: $201.7M (+308.6%); EPS: $0.95 (+215.9%).
Cash flow ops (9 mo.): $1,391.8M (+0.7%).
Repurchased ~30.6M common shares at an average cost of $57.14 per share.
Shares down 5% after hours.
Previously: DaVita HealthCare Partners EPS beats by $0.29, beats on revenue (Nov. 5)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.